The Scandinavian Pharmaceutical Market Outlook to 2013: Policy environment, market structure, pipeline analysis, growth opportunities – Aarkstore Enterprise

The Scandinavian Pharma Market Outlook to 2013: Policy environment, market structure, pipeline analysis and growth opportunities

The Scandinavian healthcare system and pharmaceutical market is well regulated, with the state bearing responsibility for a large proportion of an individual’s pharmaceutical expenses. Solidarity and equality are the ideological basis of these welfare states, and a significant public commitment exists towards ensuring access to high quality health care for all citizens. Sweden and Denmark have been the two biggest pharma and biotech markets in Scandinavia, while regional players such as Novo Nordisk have laid the foundations for this industry in the region.

‘The Scandinavian Pharmaceutical Market Outlook to 2013’ is a report published explores the healthcare systems and policy environments of Denmark, Norway, Sweden and Finland. This report examines the region’s market potential by assessing historic epidemiological data, sales trends, competitive intelligence and clinical data across each major country. The growth drivers of the region are identified and forecasts for major prescription drugs and markets are provided for the period 2009-13. The competitive landscape of the Scandinavian market is also evaluated, with the region’s five leading companies being assessed based upon their marketed product portfolios and R&D pipelines in order to forecast their future competitive positions.

Key Findings

The Scandinavian pharma market recorded sales of $10.1bn in 2007, a 16% increase over 2006. Sweden had the largest market share (38%), followed by Finland (23%), Denmark (22%), and Norway (17%). These countries possess developed infrastructures, advanced technologies, R&D support and business friendly cultures. Pfizer led the Scandinavian market in 2007 with sales of $696m, a 6.3% increase over 2006.

Pfizer has a significant presence in all four Scandinavian markets and in the leading therapeutic areas of the region. Drugs for the treatment of CNS disorders are the largest product class in Scandinavia, with a market share of 20.7% in 2007. Cancer and cardiovascular diseases are the next largest therapeutic categories in the region.

Well-developed biotech and life sciences clusters across the Scandinavian region enable world-class research and provide pools of well-educated personnel and versatile facilities to support start-up companies.

Parallel trade has become a major concern for the profitability of Scandinavia-based Pharma companies in recent years. Factors driving this include lower prescription drug expenditures sought by payors and parallel traders’ strategies benefit from price differentials for drugs across different countries.

Use this report to…

• Compare the healthcare markets of key Scandinavian countries with this report’s macroeconomic analysis of infrastructure, per capita health expenditure and Pharma sales growth vs. GDP growth across Sweden, Finland, Denmark and Norway.

• Understand how healthcare policy environments vary across the region with this report’s examination of drug approval processes, pricing regulations and reimbursement policies in each major country.

• Identify which indications have the greatest potential to provide franchise growth with this report’s evaluation of major therapy/sub-therapy areas and leading brands, including forecast sales over the period 2009-2013.

• Measure the performances and prospects of leading companies in the Scandanavian area with this report’s strategic analysis of leading pharma corporations based on sales focus by drug class, currently marketed products and R&D pipeline portfolios.

Explore issues including…

The threat to EU health spending. Pharma activity in the Scandinavian market is focused around cost containment, but in recent years the consumption of generics and parallel imports has slowly increased. A new pricing regime linked to other European countries has also had a moderating effect on price levels in Scandinavian countries over recent years.

Higher licensing deal values. Competition for promising projects (particularly drugs that have established solid proof-of-concept data) has not only boosted the deal values overall, but also increased the quantity and average value of deals in the early stages of product development.

Parallel trade influencing pricing. The prevalence of parallel trade is having a significant impact upon state expenditure on drugs and consumer prices. In Sweden, parallel imports have been included as substitutable products in accordance with the generic substitution policy, giving significant boost to parallel imported products in the country.

Support for generic substitution of patented drugs. A report by the National Trade Estimate of the United States Trade Representative (USTR) made special mention of Finland, due to the country’s Pharma Pricing Board not always waiting for the expiry of the analogous process patent before taking action.Discover…

• What will be the major growth drivers in the Scandinavian pharma market over 2009-13?

• Which companies were the winners and losers in the Scandinavian pharma market in 2007?

• Which companies will become key players over 2009 -13?

• Which products will be affected by generic competitors over the period 2009-13?

• Which pipeline products will be the growth drivers of the future?

• Which therapy areas and indications have the highest market potential over 2009-13?

• How will the Scandinavian pharma market’s competitive landscape change by 2013?

 For more information, kindly visit :
http://www.aarkstore.com/reports/The-Scandinavian-Pharmaceutical-Market-Outlook-to-2013-Policy-environment-market-structure-pipeline-analysis-growth-opportunities-13979.html

Welcome to Aarkstore Market Research Aggregation

We specialize in providing online market business information on market research reports, books, magazines, conference booking at competitive prices, and strive to provide excellent and innovative service to our customers. We are built on the premise that reading is valuable, capable of stirring emotions and firing the imagination. Whether you’re looking for new product trends or competitive analysis of a new or existing market, Aarkstore.com has the best resource offerings and the expertise to make sure you get the right product every time. 
 
http://www.aarkstore.com

Report of Chinese Shipbuilding Industry under the International Financial Crisis, 2009

Overview on the Adjustment and Revitalization Plans of Chinese Shipping Industry issued by Chinese government in February, 2009 to supporting Chinese shipping industry: Government encourages the financial organizations to increase credit funds for ship export buyers; the current financial support policies of deep sea ships for home market will be prolonged to 2010; the government should work on the policies of encouraging the update of old ships and replacing single-shell tankers; the present shipbuilding enterprises should suspend the extension projects of shipyards and shipways; the new added central investment should used to the industry revitalization and technical reform; the government should support the high-tech ships, oceanographic engineering equipments and the research on key corollary equipments.

In 2008, Chinese accomplished shipbuilding output was 28.81 million deadweight tonnages, rising by 52.2% of last year.
The newly undertook ship orders were 58.18 million deadweight tonnages, a reduction of 40.9% of last year. Ship orders in hand were 204.6 million deadweight tonnages, increased by 28.7% compared with 2007. According to the global shipbuilding statistics of Clarksons Group, the market shares of Chinese accomplished shipbuilding output, newly undertook ship orders and ship orders in hand accounted for 29.5%, 3707% and 35.5% respectively in the world, in which Chinese accomplished shipbuilding output and ship orders in hand kept a fast growth for six consecutive years and led to the three indicators standing the second place in the world.

With the transfer of international financial crisis to the real economy, Chinese shipbuilding industry has felt the coming of strikes.

Because the strikes of international financial crisis on Chinese shipbuilding industry began to reflect in September of 2008, the whole performance of Chinese shipbuilding industry in 2008 was sound. In 2008, the newly undertook ship orders were 58.18 million deadweight tonnages and only 2.61 million deadweight tonnages in the fourth quarter, less than 5% of the whole year’s. Chinese accomplished shipbuilding output exceeded the new undertook orders from October of 2008, first consecutive reduction of monthly orders in hand over the past five years. It is predicted that Chinese accomplished shipbuilding output in 2009 will be over 40 million deadweight tonnages and 56 million deadweight tonnages of orders in hand of last year’s was scheduled to accomplish in 2009. The intervals are about 16 million deadweight tonnages. It is predicted that the newly undertook orders are only about 20 to 30 million deadweight tonnages, half or more reduction year on year. At present, Chinese ship orders in hand declined from 205 million to million deadweight tonnages in 2007 to 160 million deadweight tonnages.

With the influences of the international economic depressions, the depression of shipping market and the degeneration of financial environment led to three difficulties for Chinese shipbuilding industry, including difficulty in takeover, difficulty in delivery and difficulty in the capital turnover.

During the prosperous period of shipping market, the delivery can be finished even though the existence of imperfection. At present, the buyers of ships usually put forward a variety of stringent requirements, postponing the delivery or canceling the orders. The phenomenon of postponing the delivery or canceling the orders has appeared recently. From the end of 2008 and the beginning of 2009, Cosco Corp. (Singapore) Ltd announced their buyers canceling four- ship orders and postponing payment for several ships.

The reason for postponing the payment or canceling the orders is that the declining of financial credit and the difficulty in funds for buyers. In addition, China accounted for a large part of orders in hand.

With the more and more intensive of financial crisis, the buyers are hard to fund and some even deserted the ship orders.

Compared with the difficulty in delivery and takeover, Chinese shipbuilding enterprises concerned more about the capitals. The most difficulty for shipbuilding enterprises is the capital turnover. The enterprises depended on the buyers` advance charge to maintain their capital turnover. If they did not receive new orders and breakthrough their capital chains, they would be hurt deadly. Once the capital turnover problems occurred, they had to loan from the banks, thus the operation costs added.

In February 2009, Chinese government issued the Adjustment and Revitalization Plans of Chinese Shipping Industry, showing the Chinese government’s determination to support shipbuilding industry.

Chinese shipbuilding industry, obsessed by the difficulty in takeover, delivery and capital turnover, had very great hopes of the Adjustment and Revitalization Plans of Chinese Shipping Industry. Chinese shipbuilding industry benefited most from the preferential policies on credit loan and tax.
Description

From 2004, Chinese shipbuilding industry saw sustainable and rapid development, which attracted massive capitals to shipbuilding industry, leading to the surplus of shipbuilding capacity and the tardy of creativity. According to the statistics, the yield capacity of Chinese shipbuilding industry was more than 60 million tons by the end of 2008, over the actual demands and belonging to serious surplus of yield capacity.

Opportunities still exists in Chinese market. On the one hand, Chinese domestic demands are huge. Massive domestic old ships need reform. Some ships in inland rivers and lakes can not meet the demands and need upgrade because of low technology and discharge capacity. Chinese shipbuilding industry can also better cooperate with pelagic fishing and the exploitation and construction industry of deep sea oil and gas. Meanwhile, the shipbuilding costs in China are lower than the major competitors of Japan and South Korea.

Under the present economic situation, the competitions among Chinese, Japan and South Korea are fiercer because of supply exceeding demands in the international market. If you want to receive more orders, you should provide high cost performance of the products. The most advantage for Chinese shipbuilding enterprises lies at their prices.

International financial crisis brings difficulties for Chinese shipbuilding industry, but it also brings the replacement of lagging yield capacity, concentration of shipbuilding capacity and the improvement of research and marketing abilities.

With more and more obvious of the advantages in Chinese shipbuilding industry, the international orders are transferring fast to China. At present, China has acquired the objective conditions as the shipbuilding center in the world: huge ship markets, low costs, governments` policy supports and abundant raw materials, especially the huge ship markets and low costs will become the advantages ahead of Japan and South Korea

The author wrote this report by investigating into Chinese Shipbuilding Industry and citing abundant valuable second-hand information.

Readers can obtain more following information:
- Present Development of Chinese Shipbuilding Industry
- Factors Affecting the Development of Chinese Shipbuilding Industry
- Merits and Demerits of Chinese Shipbuilding Industry
- Exports of Chinese Shipbuilding Industry
- Competitive Ability of Chinese Shipbuilding Industry in the International Market
-Influences of International Financial Crisis on Chinese Shipbuilding Industry
-Influences of Adjustment and Revitalization Plans of Chinese Shipping Industry on Chinese Shipbuilding Industry

For more information, kindly visit :
http://www.aarkstore.com/reports/Report-of-Chinese-Shipbuilding-Industry-under-the-International-Financial-Crisis-2009-12841.html